Similarly, in gastric cancer research, the MTH1 inhibitor TH287 was found to exert a range of anticancer effects on gastric cancer cells, impacting mitochondrial function and the PI3K/AKT signaling pathway (Zhan et al., 2020). Here, AKT1 is linked to gastric cancer.